1. Home
  2. PMTS vs KRRO Comparison

PMTS vs KRRO Comparison

Compare PMTS & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPI Card Group Inc.

PMTS

CPI Card Group Inc.

HOLD

Current Price

$17.42

Market Cap

152.4M

Sector

Finance

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$12.58

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMTS
KRRO
Founded
2007
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.4M
150.0M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
PMTS
KRRO
Price
$17.42
$12.58
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$27.67
$34.80
AVG Volume (30 Days)
36.7K
144.5K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.25
N/A
Revenue
$312,189,000.00
$6,392,000.00
Revenue This Year
$9.95
N/A
Revenue Next Year
$10.02
N/A
P/E Ratio
$14.67
N/A
Revenue Growth
12.27
181.46
52 Week Low
$10.81
$5.20
52 Week High
$27.31
$55.89

Technical Indicators

Market Signals
Indicator
PMTS
KRRO
Relative Strength Index (RSI) 52.07 47.56
Support Level $13.01 $12.51
Resistance Level $18.09 $14.76
Average True Range (ATR) 1.04 0.77
MACD -0.13 -0.19
Stochastic Oscillator 16.72 10.05

Price Performance

Historical Comparison
PMTS
KRRO

About PMTS CPI Card Group Inc.

CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: